Laboratorio de Neurofarmacología, FCQ-Benemérita Universidad Autónoma de Puebla, Puebla, Mexico.
Neurosci Res. 2012 Oct;74(2):156-67. doi: 10.1016/j.neures.2012.08.006. Epub 2012 Sep 1.
We have previously shown that the intrastriatal injection of the C-terminal domain of tetanus toxin (Hc-TeTx) protects the nigrostriatal-dopaminergic pathways and improves motor behavior in hemiparkinsonism-rat models caused by MPP(+) (1-methyl-4-phenylpyridinium). Here we have investigated the protective effects of the intramuscular application of the Hc-TeTx on motor asymmetry and neurodegeneration in the striatum of 6-hydroxydopamine (6-OHDA)-treated rats. Adult male rats were intramuscularly injected with the recombinant Hc-TeTx protein (0.1-20μg/kg, daily) 3days before the stereotaxic injection of 6-OHDA into the left striatum. Our results showed that the motor-improvement functions were extended for 4weeks in all Hc-TeTx-treated groups, obtaining the maximum performance with the highest dose of Hc-TeTx (20μg/kg). The improvements found were 97%, 87%, and 70% in the turning behavior, stepping test, and cylinder test, respectively. The striatal levels of dopamine and its metabolites did not vary compared to the control group. Moreover, the peripheral treatment with Hc-TeTx in rats prevents, for 30days, the neurodegeneration in the striatum caused by the toxicity of the 6-OHDA. Our results lead us to believe that the Hc-TeTx could be a potential therapeutic agent in pathologies caused by impairment of dopaminergic innervations such as Parkinson's disease.
我们之前已经表明,破伤风毒素 C 端结构域(Hc-TeTx)的纹内注射可保护黑质纹状体多巴胺能通路,并改善 MPP+(1-甲基-4-苯基吡啶)引起的半帕金森病大鼠模型的运动行为。在这里,我们研究了 Hc-TeTx 肌肉内应用对 6-羟多巴胺(6-OHDA)处理大鼠纹状体运动不对称和神经退行性变的保护作用。成年雄性大鼠在立体定向注射 6-OHDA 到左侧纹状体前 3 天,肌肉内注射重组 Hc-TeTx 蛋白(0.1-20μg/kg,每日)。我们的结果表明,所有 Hc-TeTx 治疗组的运动改善功能延长了 4 周,最高剂量的 Hc-TeTx(20μg/kg)获得了最佳效果。在转弯行为、踏步试验和圆筒试验中,改善幅度分别为 97%、87%和 70%。与对照组相比,纹状体中的多巴胺及其代谢物水平没有变化。此外,Hc-TeTx 在大鼠中的外周治疗可防止 6-OHDA 毒性引起的纹状体神经退行性变长达 30 天。我们的结果使我们相信,Hc-TeTx 可能是一种潜在的治疗剂,可用于治疗多巴胺能神经支配受损引起的疾病,如帕金森病。